Molecular classification of spontaneous endometrial adenocarcinomas in BDII rats
2009 (English)In: Endocrine-Related Cancer, ISSN 1351-0088, E-ISSN 1479-6821, Vol. 16, no 1, p. 99-111Article in journal (Refereed) Published
Abstract [en]
Female rats of the BDII/Han inbred strain are prone to spontaneously develop endometrial carcinomas (EC) that in cell biology and pathogenesis are very similar to those of human. Human EC are classified into two major groups: Type I displays endometroid histology, is hormone-dependent, and characterized by frequent microsatellite instability and PTEN, K-RAS, and CTNNB1 (β-Catenin) mutations; Type II shows non-endometrioid histology, is hormone-unrelated, displays recurrent TP53 mutation, CDKN2A (P16) inactivation, over-expression of ERBB2 (Her2/neu), and reduced CDH1 (Cadherin 1 or E-Cadherin) expression. However, many human EC have overlapping clinical, morphologic, immunohistochemical, and molecular features of types I and II. The EC developed in BDII rats can be related to type I tumors, since they are hormone-related and histologically from endometrioid type. Here, we combined gene sequencing (Pten, Ifr1, and Ctnnb1) and real-time gene expression analysis (Pten, Cdh1, P16, Erbb2, Ctnnb1, Tp53, and Irf1) to further characterize molecular alterations in this tumor model with respect to different subtypes of EC in humans. No mutation in Pten and Ctnnb1 was detected, whereas three tumors displayed sequence aberrations of the Irf1 gene. Significant down regulation of Pten, Cdh1, p16, Erbb2, and Ctnnb1 gene products was found in the tumors. In conclusion, our data suggest that molecular features of spontaneous EC in BDII rats can be related to higher-grade human type I tumors and thus, this model represents an excellent experimental tool for research on this malignancy in human.
Place, publisher, year, edition, pages
Bioscientifica, 2009. Vol. 16, no 1, p. 99-111
National Category
Cell and Molecular Biology Cancer and Oncology Medical Genetics and Genomics
Identifiers
URN: urn:nbn:se:his:diva-22946DOI: 10.1677/erc-08-0185ISI: 000265418500007PubMedID: 19075038Scopus ID: 2-s2.0-65549161901OAI: oai:DiVA.org:his-22946DiVA, id: diva2:1779433
Funder
Swedish Cancer SocietyRoyal Physiographic Society in LundStiftelsen Assar Gabrielssons fondWilhelm och Martina Lundgrens VetenskapsfondAdlerbertska Research FoundationKnut and Alice Wallenberg Foundation
Note
Society for Endocrinology
Funding
This work was supported by The Swedish Cancer Society, The Gunvor and Ivan Svenssons Foundation. The Royal Physiographic Society in Lund (Nilsson-Ehle Foundation), The Assar Gabrielsson Foundation, The Wilhelm and Martina Lundgren's Foundation, and The Adlerbertska Foundation.
Acknowledgements
We are grateful to Cecilia Börjesson and Dr Åsa Sjöling for their valuable contribution to this manuscript. The real-time PCR was performed at the Genomics Core Facility platform at the Sahlgrenska Academy, University of Gothenburg, which was funded by a grant from the Knut and Alice Wallenberg Foundation.
2023-07-042023-07-042025-02-10Bibliographically approved